LIC 2019 Program click front or back cover to download

Rising to the Challenge JANUARY 16 -17, 2019 | TRANSCORP HILTON, ABUJA, NIGERIA

SPEAKERS Umaru Tanko Al-Makura, Executive Governor, Nassarawa State Nigeria I Prof. Oyewale Tomori, Chair, National Lassa fever Steering Committee, Nigeria I Prof. Sylvanus Okogbenin, CMD, Irrua Specialist Teaching Hospital, Irrua, Nigeria I Mrs. Elsie Ilori, Technical Team Lead, National Lassa Fever Working Group, Nigeria I Dr. Pierre Formenty, Team Lead – VHF, WHO I Prof. Stephan Gunther, HOD Virology, Bernard Nocht Institute for Tropical Medicine, Germany I Prof. William Kwabena Ampofo, HOD Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra I Prof. Daniel Bausch, Director, UK Public Health Rapid Support Team, United Kingdom I Prof. Christian Happi, Director, Africa Centre of Excellence for Genomics of Infectious Diseases, Reedemers University, Nigeria I Dr Richard J. Hatchett, Chief Executive Officer, Coalition for Epidemic Preparedness Innovations (CEPI) I Dr. David Eseile Eseigbe, Alliance for International Medical Actions(ALIMA)/Federal Medical Centre Owo

FOLLOW THE CONVERSATION

#LIC2019

LASSA FEVER International CONFERENCE

Rising to the Challenge JANUARY 16 -17, 2019 | TRANSCORP HILTON, ABUJA, NIGERIA

WELCOME TO NIGERIA It gives me great pleasure to welcome you all to the first Lassa fever International Conference, taking place in Abuja, Nigeria.

This conference is timely because of several reasons. In 2018, Nigeria experienced the largest confirmed Lassa fever cases in a single year. Also, despite the fact that the virus was first discovered in a town in Nigeria fifty years ago, we still continue to experience yearly outbreaks.

In the Democratic Republic of Congo, we have concurrent outbreaks of Ebola, occurring within weeks of each other and in geographically dispersed areas. It is clear that the changing environment and population dynamics, along with the improved capability to detect these cases is also increasing. Therefore, we have to continuously build resilient health systems that can prevent, prepare, detect, respond to and control these infectious disease outbreaks.

Most of the cases of Lassa fever in the world, occur in Nigeria, therefore we should be at the heart of the response. I am proud that the Nigeria Centre for Disease Control, together with our partners are taking on this responsibility head on. We, in Nigeria have developed a Lassa fever research

plan, which is aligned with the global Lassa fever research agenda.

I am pleased that there is a growing global focus on developing vaccines, improved diagnostics, better therapeutics and other intervention for responding to Viral hemorrhagic fevers such as Lassa fever disease. Hopefully, a few years from now, we will have more tools in our arsenal for preventing, detecting and responding to cases of Lassa fever.

We are privileged to have an excellent lineup of speakers at this conference. They all bring exceptional expertise and experience on strengthening health security globally, including their leadership in response to major disease outbreaks.

The Government of Nigeria, led by President Muhammadu Buhari GCFR, has shown an increased commitment to strengthening health security and universal health coverage. We look forward to the output from this conference which will be fully supported by the Nigerian government.

Once again, welcome to Nigeria and I wish you a successful conference.

PROF. ISAAC FOLORUNSHO ADEWOLE Honourable Minister of Health

LASSA FEVER INTERNATIONAL CONFERENCE

With over 700 people registered at this year’s conference, 302 abstracts received, 160 oral and poster presentations, we are very confident we will have an amazing two days together- defining the future of Lassa fever globally.

WELCOME TO LIC 2019 We are very pleased to welcome you all to the first Lassa fever International Conference.

About fifty years ago, in a town in North-East Nigeria, the Lassa fever virus was discovered for the first time. Half a century later, we have made some progress but not as much as we know we can. Lassa fever research and response has been fragmented and sporadic, led by a few enthusiasts, who have kept up their engagement despite the lack of concerted support on the national and global fronts.

Between January and May 2018, we experienced what has been described as the largest outbreak of Lassa fever ever recorded. In response, we sent out preventive messages across various platforms as health care workers were reporting more cases. We expanded our capacity to test for cases with new laboratories as the case count continued to rise. That outbreak spurred us to think - How much do we really know about Lassa fever? Is our knowledge sufficient to guide the response? We concluded that the answer was ‘no’.

We are therefore grateful for the increasing global focus on Lassa fever virus, including its inclusion in the WHO Blueprint for Research and Development Preparedness. There is no better time than now for us to converge and define a roadmap for the future of Lassa fever together.

The idea to organise this conference came from various sources, especially Professor Oyewale Tomori who is one of our plenary speakers and who has been part of the 4

LASSA FEVER INTERNATIONAL CONFERENCE

Thanks to our partners, we are able to sponsor over 90 researchers from Nigeria and other West African countries to attend the conference.

Lassa fever story in Nigeria. We have a great line-up of speakers that will help us better understand the history, the current status and how we can improve our current knowledge of the virus, in order to better prevent, detect and control.

We are very grateful to our conference sponsors and partners- Coalition for Epidemic Preparedness Initiative (CEPI), Bernard Nocht Institute, WHO, UK Public Health Rapid Support Team (UK PHRST), Africa CDC, University of Maryland Baltimore, MSF, UNICEF, AFENET, ISARIC, Foundation for Innovative Diagnostics (FIND), Nigerian Institute of Medical Research, National Primary Healthcare Development Agency and the National Agency for the Control of AIDS for funding one or more conference areas.

Thanks to our partners, we are able to sponsor over 90 researchers from Nigeria and other West African countries to attend the conference. With over 700 people registered at this year’s conference, 302 abstracts received, 160 oral and poster presentations, we are very confident we will have an amazing two days together– defining the future of Lassa fever globally.

Critically, this marks the rise of the Nigeria Centre for Disease Control as a sciencedriven organisation. We will strive to live up to this vision.

Welcome to Nigeria!

CHIKWE IHEKWEAZU, Conference co-chair

ELSIE ILORI, Conference co-chair

5

LASSA FEVER INTERNATIONAL CONFERENCE

TABLE OF CONTENT WELCOME TO NGERIA WELCOME TO LIC 2019 LIC 2019 ORGANISING COMMITTEE. GENERAL INFORMATION Conference side meetings, cocktail and networking sessions Post conference city tour PROGRAM AT A GLANCE SPONSORS EXHIBITORS

4 7

9

11

12 13 17

18

Conference SPEAKERS

19

Conference PANELISTS

22

PRESENTATION SCHEDULE

23

Plenary Session 1: Wednesday, 16th January, 2019 Parallel Session 1: Wednesday, 16th January, 2019 Plenary Session 2: Thursday, 17th January, 2019 Parallel Session 2: Thursday, 17th January, 2019 Poster Directory TRAVEL GRANT AWARDEES DIRECTORY

6

3

23 23

30 30 35 41

LASSA FEVER INTERNATIONAL CONFERENCE

LIC 2019 ORGANISING COMMITTEES AND MEMBERS LOCAL ORGANISING PLANNING COMMITTEE Chikwe Ihekweazu – LOC Chairman Elsie Ilori – LOC Secretary Chioma Dan-Nwafor – LOC Asst. Secretary I Anthony Ahumibe – LOC Asst. Secretary II Ikechukwu Okogwu – LOC Account Team Leads and Secretaries of each subcommittee Partners Advocacy and Resource mobilisation subcommittee Joshua Obasanya – Lead Olufemi Ayoola – Secretary Adebayo Adedeji Hanatu Bello John Oladejo Nwando Mba Olubunmi Ojo Scientific subcommittee Emmanuel Agogo – Lead Abiodun Ogunniyi Adebola Olayinka Banji Ipadeola Belu Bio Abaye Dhamari Naidoo Gbetsere Aghogho Ifeanyi Okudo Muhammad Saleh Nma Okoli Olaolu Aderinola Oyeladun Okunromade

Samuel Mutbam Sola Aruna Timothy Ajani Tochi Okwor Winifred Ukponu Adesola Yinka Ogunleye Publications subcommittee Abiodun Egwuenu – Lead Boboye Onduku – Secretary Adaora Ejikeme Adunola Oyegoke Emmanuel Omomoh Emeka Uzoho Fatima Garba Henry Ekechi Idayat Temitope Ifeayinchukwu Kalu Mfon Obong Rahab Amaza Rhoda Atteh Simon Okoli Sola Sunday Solomon Okoli Williams Nwachukwu InfoRMATION, Communication & Tech subcommittee Lawal Bakare – Lead Uchenna Iwuzor – Secretary Akanimo Iniobong Chinedu Arinze Emeka Oguanuo 7

LASSA FEVER INTERNATIONAL CONFERENCE

LIC 2019 ORGANISING COMMITTEES AND MEMBERS Emmanuel Benyeogor Ferdinand Oyiri Jerry Agenyi Gerald Manyo Ndoma Medical subcommittee Fatima Saleh - Lead Obiefuna Ejezie - Secretary Adama Ahmad Chinwe Ochu Denis Bunyoga Dike Kingsley Tina Ekuwazi Security subcommittee

Sebastian Yennan – Lead Anwar Abubakar – Secretary Akin Akinwunmi Michael Popoola Sadiq Garba Protocol subcommittee

Womi Eteng – Lead Tarik Mohammed – Secretary Edidiong Evans Miracle Rufus Oyeronke Oyebanji

8

Socials subcommittee

Gbenga Akingbiyi – Lead

Damilola Kolade – Secretary Amedu Michael Chimezie Anueyiagu Favour Makava Media relations and publicity subcommittee

Jerry Agenyi – Lead Chimezie Anueyiagu – Secretary Lawal Bakare Logistics subcommittee Yakubu Abdullahi – Lead Chibuzo Eneh – Secretary Aisha Inwa Akeem Alaka Gbenga Joseph Rimamdeyati Yashe Registration subcommittee Nanpring Dawn Williams – Lead Munachimso Dim – Secretary Amina Mohammed Bolanle Onilogbo Buchi Okoro Hwoja Jah Jennifer Dim Joke Akano Judith Onyeneke Rosemary Olorundare

LASSA FEVER INTERNATIONAL CONFERENCE

GENERAL INFORMATION REGISTRATION AND BADGES The registration desk is open from 07:00hrs to 18:00hrs on 16th January 2019 at the Congress Hall Foyer. Security checks will begin at the entrance to the Congress Hall.

Badges must be worn at all times during the official meetings and will be required for entry to the Congress Hall area, parallel rooms, lunch marquee, cocktail reception areas. Lost badges may be replaced at the registration desk. Your official ID will be required for verification prior to the re-issue of your badge.

CERTIFICATE OF ATTENDANCE AND CME CREDITS The certificate of attendance will be available electronically for individuals who complete the LIC post conference evaluation. Please check your email after the conference for the link to the survey.

Continuing Medical Education (CME) credits are also available to healthcare professionals that require such. Visit the registration desk for the procedure for CME credits.

ABSTRACTS AND PRESENTATION The conference programme with list of accepted abstracts has been published on the conference website.

Parallel sessions will hold in four breakout rooms. All scientific oral presentations should have been sent to lfconference@ncdc.gov.ng by 13th January 2018.

Posters will be displayed and presented at the Congress Hall Foyer. Poster presenters can put up their posters from 15th January 2019 latest by 20:00hrs. All posters must be taken down at 18:00hrs on 17th January 2019.

LOGISTICS

Complimentary airport shuttle is available for guests from outside Nigeria and all our travel scholars. Conference shuttle buses will also be available from the following conference hotels to the conference venue and back: •

Sheraton Hotel, Wuse Zone 4

•

Pennsylvania Hotel, Jabi

•

Grand Cubana Hotel, Jabi

Uber taxi service is also available in Abuja.

9

LASSA FEVER INTERNATIONAL CONFERENCE

GENERAL INFORMATION TIME FOR SHUTTLE BUSES TO CONFERENCE VENUE Pick up from hotels, December 15 – 16, 2019: 07:30hrs Drop off from Hilton, December 15 – 16, 2019: 21:00hrs Contact details for airport pick up: Damilola Kolade – +234 701 842 0445 and Anwar Abubakar – +234 813 383 8313 CURRENCY

The local currency is the Nigerian Naira (NGN). Automated Teller Machines (ATMs) and banks are available at the Hilton Hotel and around the city. Please be aware of your surroundings when using an ATM. Remember to notify your credit card issuer that you are in Nigeria.

MEALS

Please check with your hotel to confirm if breakfast is included in your room rate. Morning and evening tea breaks and lunch will be provided for all conference attendees.

Tea break will be served at the Congress Hall while lunch will be served at the marquee in front of the Congress Hall.

In addition,refreshments will be available at the Welcome Cocktail Reception on 16th January 2019 (17:00 – 18:30) and the Closing Reception on 17th January 2019 (17:30 – 18:30).

MEDICALS

If you are in need of first aid, a member of the LIC Medical Team will attend to you at the Hilton Hotel.

The referral hospital is the National Hospital, Abuja and transfers will be arranged as needed. The medical team is located at the Congress Hall foyer.

Contact details: Fatima Saleh – +234 803 615 0927

10

LASSA FEVER INTERNATIONAL CONFERENCE

Conference side meetings, cocktail and networking sessions CONFERENCE SIDE MEETINGS 15th January 2019

National Lassa fever Research Consortium meeting (strictly by invitation)

15th January 2019

Ribavirin RCT group meeting (strictly by invitation)

15th January 2019

CEPI Ghana follow-up meeting (strictly by invitation)

18th January 2019

CEPI Joint Coordination Meeting (strictly by invitation)

18th – 19th January 2019

Social Science preparedness on Lassa fever Research Workshop (strictly by invitation)

19th January 2019:

Lassa fever Community Transmission Meeting (strictly by invitation)

CONFERENCE SOCIAL EVENTS 16th January 2019

Opening reception and cocktail night- Fountain side, Transcorp Hilton

17th January 2019

Closing reception (sponsored by ACDC) - Congress Hall, Transcorp Hilton

17th January 2019

Welcome event for JCG attendees and members, sponsored by CEPI (strictly by invitation)

18th January 2019

Conference tour

11

LASSA FEVER INTERNATIONAL CONFERENCE

Post conference city tour We are excited to host you in Abuja for the Lassa fever International Conference. We recognise this will be the first visit to Nigeria for some of you and we hope that it will be enjoyable. We are organising a post-conference tour, to visit the places listed below, and ending up at the NCDC Headquarters at Jabi, Abuja. Tour buses, security, photography and lunch will be provided. Registration closed on the 10th of January 2019 (pre-registration was required).

Time: 7:00a.m. – 12 noon Date: 18th January, 2019

Muster Point: 6:45a.m. at the main entrance of Transcorp Hilton, Abuja Locations to be visited:

1. Sarius Palmetum Botanical Center is the biggest botanical garden in the city. The garden is filled with a variety of attractive plants and flowers. This 21-hectare resort is owned by Mrs Ajoke Mohammed, wife of Nigeria’s former Head of State, late Gen.Murtala Muhammad.

2. The Centre for Arts and Culture in Area 10, Garki, is named after a famous Nigerian writer, Cyprian Ekwensi. It is a centre where spectacular art-works, festivals and various exhibitions are show-cased.

3. The Abuja National Stadium is the home of the Nigerian football team, where various football matches as well as other cultural and social events take place. The stadium was launched in April 2003 and hosted the 8th All Africa Games in October that year. The main bowl has a 60,000 seating capacity.

4. Ecumenical Centre also known as the National Christian Centre is one of the largest churches in Abuja. This landmark is one of the most remarkable architectural works of the city. Visitors can view pivotal arches leading to the central altar surrounded by the colourful church windows.

5. The Abuja National Mosque built in 1984 is located in the Central Area. The golden dome and the four minarets of the mosque can be seen from a distance. It is not only a place of worship for the Muslims but also a learning centre for Islamic studies.

6. Kayak Abuja at package B of the Abuja National stadium offers recreational water activities. Colourful kayaks which visitors can rent and row themselves in the tranquil artificial lake are available. These are available within the sports complex of the Stadium.

7. A stop for free local food tasting at Orishirishi where you can explore a variety of traditional Nigerian dishes including the famous Nigerian jollof rice.

8. Nigeria Centre for Disease Control Emergency Operations Centre

Enquiries: Send a mail to lfconference@ncdc.gov.ng or contact Damilola Kolade on +234 701 842 0445 12

LASSA FEVER INTERNATIONAL CONFERENCE

PROGRAMME AT A GLANCE DAY 1 – WEDNESDAY, January 16, 2019

7:00 – 8.30

Registration

8:30 – 9:00

Opening and welcome address Conference co-chairs: Chikwe Ihekweazu and Elsie Ilori

9:00 – 10:45

Plenary Chairs: Sunday Omilabu and Joshua Obasanya Nigeria’s 2018 Lassa fever outbreak and lessons for the future Elsie Ilori The Irrua Specialist Teaching Hospital’s role in the fight against Lassa fever in Nigeria Sylvanus Okogbenin How a North-South relationship has improved our understanding of Lassa fever globally Stephan Gunther CEPI’s role in the opportunity and responsibility for clinical trials in Africa Richard Hatchett

10:45 – 11:15

Coffee Break

11:15 – 13:15

Parallel Sessions Case management Animal and environmental health response Laboratory Surveillance and Diagnostics Vaccines and Innovations

13:15 – 14:00

Exhibition and poster viewing

14:00 – 15:00

Lunch Break

15:00 – 17:30

Opening Ceremony

17:00 – 18:30

Reception and Welcome Night 13

LASSA FEVER INTERNATIONAL CONFERENCE

PROGRAMME AT A GLANCE DAY 2 – THURSDAY, January 17, 2019 08:30 - 9:00

Welcome and House Keeping

9:00 – 10:45

Plenary Chairs: Adebola Olayinka and Ephraim Ogbaini Lassa fever: a historical perspective and contemporary development in Sierra Leone Daniel Bausch New approaches in shaping the global response to VHFs (Therapeutics and Vaccines) Pierre Formenty What do we really know about the Mastomys as host?

William Ampofo Using genomic sequencing to fight outbreaks in Africa Christian Happi

10:45 – 11:15

11:15 – 13:00

Coffee Break Poster viewing and interactive session

13:00 – 14:00

Lunch Break

14:00 – 15:30

Parallel Sessions Epidemiology and Surveillance Policy and Co-ordination of response Infection Prevention and Control Risk communications and community engagement

15:30 – 16:30

Plenary Battling Lassa fever viral infection: a survivor’s story – David Eseile Lessons learnt in rising to the Lassa fever challenge – Patrick Nguku

16.30 – 17.30

Closing ceremony and awards

17:30 – 18:30

Cocktail and networking

14

LASSA FEVER INTERNATIONAL CONFERENCE

PROGRAMME AT A GLANCE Opening Ceremony Agenda – WEDNESDAY, January 16, 2019 14:50 - 15:00

Musical interlude

10mins

15:00 - 15:05

National Anthem

5 mins

15:05 - 15:15

Introduction of Dignitaries

10 mins

15:15 – 15:30

Welcome by the DG, Nigeria CDC

15 mins

15:30 – 16:20

Plenary Chairs: Babatunde Salako and Olubunmi Ojo

16:20 – 17:00

Quinquagenary of a Nigeria conundrum: Fifty years of the Lassa fever– Hotter, Bigger and Longer – Oyewale Tomori

20 mins

Presentation by Tanko Al-Makura, Executive Governor, Nassarawa State

20 mins

Panel discussion

40 mins

Moderator: Ibrahima Soce Fall, Director of Regional Health Emergencies WHO AFRO David Heymann, Head of Centre on Global Health Security, Chatham House Faisal Shuaib, Executive Director, National Primary Health Care Development Agency Philip Onyebujoh, Senior Policy Advisor to the Director Africa Centres for Disease Control Niniola Soleye, Executive Director, Dr Ameyo Stella Adadevoh Foundation Njidda M. Gadzama, Professor Emeritus of Zoology and Environmental Science, University of Maiduguri, Borno State, Nigeria Sylvie Briand, Director Infectious Hazards Management, World Health Organization 17:00 – 17:20

Remarks by Honourable Minister of State For Health

20 mins

17:20 – 17:30

Official conference opening

20 mins

17:30 – 18:30

Cocktail and networking

Comperes: Emmanuel Agogo and Inya Ode 15

LASSA FEVER INTERNATIONAL CONFERENCE

PROGRAMME AT A GLANCE CLOSING Ceremony Agenda – THURSDAY, January 17, 2019

16:30 - 16:35

National Anthem

16:35 – 16:40

Introduction of award categories

16:40 – 17:00

Award presentation

17:00 – 17:20

Reflection on lessons from the conference and the future for global health

17:20 – 17:30

Vote of thanks

Comperes: Emmanuel Agogo and Inya Ode

16

LASSA FEVER INTERNATIONAL CONFERENCE

SPONSORS Thanks to our partners – Coalition for Epidemic Preparedness Initiative (CEPI), Bernard Nocht Institute, UK Public Health Rapid Support Team (UK PHRST) and Foundation for Innovative Diagnostics (FIND). With their support, we have offered over 90 travel grants to attendees from Nigeria and West Africa. We remain very grateful to other conference partnersWHO, Africa CDC, University of Maryland Baltimore, MSF, UNICEF, AFENET, ISARIC, Nigerian Institute of Medical Research, National Primary Healthcare Development Agency and the National Agency for the Control of AIDS for their support and partnership.

17

LASSA FEVER INTERNATIONAL CONFERENCE

EXHIBITORS

CEPI – the Coalition for Epidemic Preparedness Innovations – is a new alliance to finance and coordinate the development of new vaccines to prevent and contain infectious disease epidemics. http://cepi.net

WHO is building a better, healthier future for people all over the world. Working with 194 Member States, across six regions, and from more than 150 offices, WHO staff are united in a shared commitment to achieve better health for everyone, everywhere. https://www.who.int

MSF provides medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare.

Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. www.msf.org

The Nigeria Centre for Disease Control (NCDC) was establishedWd response to epidemics through prevention, detection, and control of communicable diseases. https://ncdc.gov.ng 18

The African Field Epidemiology Network (AFENET) is a non-profit and networking alliance of African Field Epidemiology (and Laboratory) Training Programs (FELTPs), and other applied epidemiology training programs.

AFENET iis helping ministries of Health in Africa build strong, effective, and sustainable programs with capacity to improve public health systems partnering with global public health experts. http://afenetnigeria.net

Future Concerns is an intelligent one-stop safety resource featuring authorised Blue chip distribution hubs amidst services, maintanance and training centers along side prescription vision safety lab all to highest global safety standards. https://www.futureconcerns.com

Unigloves specializes in the manufacture and supply of premium quality medical gloves in Nigeria, both latex and non-latex alternatives. We are also key distributors of infection control and wound care products of our partners who are particular about quality. http://www.unimedicalhealthcare.com

LASSA FEVER INTERNATIONAL CONFERENCE

Conference SPEAKERS Umaru Tanko Al-Makura A presentation

Prof. Oyewale Tomori Lassa Fever in Nigeria: Fifty Years After

His Excellency, Tanko AlMakura, is the Executive Governor of Nassarawa State.

Professor Tomori is a Fellow of the Nigerian Academy of Science and a member of the U.S. National Academy of Medicine. He is a professor of virology and has been involved in the investigations of VHF outbreaks in many African countries. Professor Tomori is currently the Chair of the National Laboratory Technical Working Group.

Prof. Sylvanus Akhalufo Okogbenin The Irrua Specialist Teaching Hospital’s role in the fight against Lassa fever in Nigeria Professor Okogbenin is the Chief Medical Director of Irrua Specialist Teaching Hospital the Irrua Specialist Teaching Hospital and a Professor of Obstetrics and Gynaecology at the Ambrose Alli University. Prof. Okogbenin is one of the leading authorities on the management of Lassa fever in pregnant women.

Dr. Pierre Formenty New approaches in shaping the global response to VHFs (Therapeutics and Vaccines) Dr Formenty is the Manager of the WHO Emerging and Dangerous Pathogens Laboratory Network (EDPLN), a Network of high security diagnostic laboratories for early detection and rapid containment of outbreaks due to emerging and dangerous pathogens. He is a Veterinarian who is also trained in Public Health and has been with the WHO since 1996.

Mrs. Elsie Ilori Nigeria’s 2018 Lassa fever outbreak and lessons for the future Mrs Elsie Ilori is a Deputy Director in the Department of Surveillance at the Nigeria Centre for Disease Control. She leads the National Lassa fever Technical Working Group and she was the Incident Manager (IM) for the National Lassa fever Emergency Operation Centre (LF-EOC) at the NCDC in 2018.

19

LASSA FEVER INTERNATIONAL CONFERENCE

Conference SPEAKERS Prof. Stephan Günther (MD) How a North-South relationship has improved our understanding of Lassa fever globally Professor Gunther is the Head of Department of Virology, the Biosafety level 4 laboratory at the BernhardNocht-Institute for Tropical Medicine in Hamburg, Germany. His research is focused on to viral hemorrhagic fevers, including Ebola virus disease, Lassa fever, and Crimean-Congo hemorrhagic fever.

Dr. Daniel Bausch Lassa fever: a historical perspective and contemporary development in Sierra Leone Dr Bausch is the Director of the United Kingdom Public Health Rapid Support Team (UK PHRST), a specialized emerging tropical viruses’ response and research team jointly set up by Public Health England and the London School of Hygiene and Tropical Medicine. He has experience in combating viruses such as Ebola, Lassa, hantavirus, and SARS coronavirus.

20

Prof. William Kwabena Ampofo What do we really know about the Mastomys as host?

Professor Ampofo heads the Department of Virology at the Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana. He established the National Influenza Centre in Ghana in 2007 and supervised the laboratory detection of the first ever cases of Lassa fever virus infection in humans and rodents in Ghana in 2011.

Prof. Christian Tientcha Happi Using genomic sequencing to fight outbreaks in Africa Professor Happi is the Director African Center of Excellence for Genomics of Infectious Diseases (ACEGID) Redeemer’s University. He is a Professor of Molecular Biology & Genomics and has made leading contributions to genomic diagnostics of Lassa fever and Ebola in Nigeria.

LASSA FEVER INTERNATIONAL CONFERENCE

Conference SPEAKERS Dr. Richard J. Hatchett (MD) CEPI’s role in the opportunity and responsibility for clinical trials in Africa

Dr. David Eseile Eseigbe Battling Lassa fever viral infection: a survivor’s story

Dr Hatchett Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership of public, private, philanthropic and civil organizations. The organisation he heads, oversees finances and coordinates the development of vaccines against high priority public health threats and vaccine platform technologies, to respond rapidly to emerging infectious diseases with pandemic or epidemic potential.

Dr. Eseigbe is a medical doctor/case management officer, working with the Alliance for International Medical Actions(ALIMA) and the Federal Medical Centre Owo at Ondo state. He specializes in managing Lassa fever cases.

21

LASSA FEVER INTERNATIONAL CONFERENCE

CONFERENCE Panelists Prof. David Heymann Professor Heyman is currently professor of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine; head of the Centre on Global Health Security at Chatham House, London. Previously he was the World Health Organization's assistant director-general for Health Security and Environment, and representative of the director-general for polio eradication.

Dr Faisal Shuaib Dr Shuaib is the Executive Director of the National Primary Health Care Development Agency in Nigeria. He is a medical doctor and public health specialist. He coordinated Nigeria’s successful response to the outbreak of Ebola Virus Disease (EVD) as the Incident Manager of the Ebola Emergency Operations Centre in 2014.

Dr Philip Onyebujoh Dr Onyebujoh is the Senior Advisor on Policy to the Director Africa Centres for Disease Control.

Prior to this, he was the HIV, TB and Hepatitis, Regional Laboratories focal point for the WHO Regional Office for Africa, based at the WHO/IST/ ESA offices in Harare.

22

Niniola Soleye Niniola Soleye is the Managing Director of DRASA (Dr. Ameyo Stella Adadevoh) Health Trust. DRASA works to reduce public health threats through the advancement of infection control practices, hygiene and sanitation behaviors, and outbreak preparedness measures in Nigeria. DRASA was established in memory of Dr. Ameyo Stella Adadevoh, the doctor who diagnosed and helped contain the first case of Ebola in Nigeria.

Prof Njidda M. Gadzama Njidda Gadzama is Professor Emeritus of Zoology and Environmental Science at University of Maiduguri, Borno State, Nigeria. He is an academic leader having been pioneer Pro-Chancellor of National Open University of Nigeria; ViceChancellor, University of Maiduguri; and the Acting Vice-Chancellor, University of Port Harcourt.

Dr Sylvie Briand Dr. Briand is currently Director of the Infectious Hazard Management (IHM) - Pandemic and Epidemic Diseases department (PED) in WHO Health Emergency Programme (WHE) at World Health Organisation. IHM-PED develops mechanisms to address epidemic diseases under the International Health Regulations. She was head of the Global Influenza Programme (GIP) during the H1N1 2009 pandemic

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE 8:30 - 9:00 Plenary 1 Chairs

Welcome address

Chikwe Ihekweazu and Elsie Ilori

Congress Hall

Day One: Wednesday, 16th January, 2019 Sunday Omilabu, Professor, Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos Joshua Obasanya, Director Prevention and Programme Coordination, NCDC

Time

Keynote Presentations

Speaker

Room

9:00 - 9:20

Nigeria’s 2018 Lassa fever outbreak and lessons for the

Elsie Ilori

Congress Hall

9:20 - 9:40

The Irrua Specialist Teaching Hospital’s role in the fight

Sylvanus

Congress Hall

9:40 - 10:00

How a North-South relationship has improved our

Stephan Gunther

Congress Hall

10:20 - 10:40

CEPI’s role in the opportunity and responsibly for

Richard Hatchett

Congress Hall

10:40 - 10:45

Question and Answer (Q&A)

All Plenary 1

Congress Hall

future

against Lassa fever in Nigeria

understanding of Lassa fever globally clinical trials in Africa

Okogbenin

Speakers

Parallel 1 Day One: Wednesday, 16th January, 2019 11:15 – 13:15

Animal and Environmental Health

Chairs

Olaniran Alabi, Director Vet and Pest Control Services, Federal Ministry of Agriculture

Time

Title

AUTHOR

Room

11:15 - 11:30

O.A-1 Trial to Reduce Mastomys natalensis Abundance in Homes in Rural Sierra Leone

Lead presenter: Alexandra Jaouiche

Edo Hall

Shakir Balogun, Resident Advisor, Nigeria Field Epidemiology and Laboratory Training Program

23

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Parallel 1 Day One: Wednesday, 16th January, 2019 Time

Title

AUTHOR

Room

11:30 - 11:38

O.A-2 Lassa Fever in Guinea and Sierra Leone: Rodent Control

Elisabeth Fichet-

Edo Hall

Joachim Marien

Edo Hall

Bamidele Ogunro

Edo Hall

and Seasonal Human Exposure to Rodents (LAROCS Project)

11:38 - 11:46

O.A-3 Evaluation of Rodent Control to Fight Lassa Fever Based on Field Experiments and Mathematical

calvet

Modelling 11:46 - 11:54

O.A-4 Detection of Antibody and Antigen Specific for Lassa

Virus Nucleoprotein in Monkeys from Southern Nigeria: It is Time to Cast a Wider Zoo-surveillance Net

11:54 - 12:02

O.A-5 Insights from an Anthropology of Domestic Space and

Almudena Mari Sรฃยกez

Edo Hall

12:02 - 12:10

O.A-6 Lassa Virus Circulation in Natural Small Mammal

Umaru Bangura

Edo Hall

12:10 - 12:18

Question and Answer (Q&A)

12:18 - 12:26

O.A-7 Investigating the Use of Indigenous Rodent Control

Dan Brunsdon

Edo Hall

12:26 - 12:34

O.A-8 The Rural Environment and Lassa Fever Endemicity in

Samuel Owoicho

Edo Hall

12:34 - 12:42

O.A-9 Land Use and Natal Multimammate Mouse Abundance

Johana Teigen

Edo Hall

12:42 - 12:50

O.A-10 Phylogenetic analysis and prevalence of Lassa virus

Adetunji Adesina

Edo Hall

Lassa Fever Research in Guinea

Populations in Bo District, Sierra Leone

Methods, in Bo Region, Sierra Leone.

Edo State Nigeria,2008-2014: a Spatial Regression

in Lassa Fever-endemic Villages of Eastern Sierra Leone in multimammate mice within the highly endemic EdoOndo hotspot for Lassa fever, Nigeria

24

Edo Hall

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Parallel 1 Day One: Wednesday, 16th January, 2019 Time

Title

AUTHOR

Room

12.50 - 12:58

O.A-11 Biosocial Dimensions of Human Contact with Potential Hemorrhagic Fever Virus Reservoirs through the Bushmeat Trade in Nigeria

Sagan Friant

Edo Hall

12.58 - 13.06

O.A-12 Impact of Climate Change on Lassa Fever: a 10-Year Trend Analysis of Lassa Fever Incidence and Climatic Elements in Edo State, Nigeria

Emmanuel Osagiede

Edo Hall

13:06- 13:13

Question and Answer (Q&A)

13:13 - 13:15

Recap of Session

Track

Case Management

Chairs

Robinson Onoh, Chairman Medical Advisory Committee, Federal Teaching Hospital, Abakaliki

Edo Hall Chairs

Edo Hall

Peter Horby, Professor of Emerging Infectious Diseases and Global Health, International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) Time

Title

AUTHOR

Room

11:15 - 11:27

O.C-1 MSF’s experience in managing Lassa fever cases in a

Lead presenter:

FCT Hall

11:27 - 11:35

O.C-2 Prevalence and Severity of Acute Kidney Injury Among

Adewale Adetunji

FCT Hall

11:35 - 11:43

O.C-3 Haemodialysis in Lassa Fever Patients with Acute Kidney

Mojeed Rafiu

FCT Hall

Titus Ibekwe

FCT Hall

pediatric reference center in Gondama (Bo), Sierra Leone Children with Lassa Fever in Edo State, Nigeria 2009 and 2017 Injury; the Experience at Irrua Specialist Teaching Hospital, a

Hilde De Clerck

Designated Treatment Facility in Nigeria from 2014 to 2018.

11:43 - 11:51

O.C-4 Early-onset Sensorineural Hearing Loss in Lassa Fever

25

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Parallel 1 Day One: Wednesday, 16th January, 2019 Time

Title

AUTHOR

ROOM

11:51 - 11:59

O.C-5 High Mortality Rates of Lassa Fever in Sierra Leone 2014-

Amara Alhaji Sheriff

FCT Hall

Sylvanus Okogbenin

FCT Hall

Josephine Alabi

FCT Hall

2017: a Descriptive Study 11:59 - 12:07

O.C-6 Analysis of Clinical Presentation of Patients with Lassa Virus Disease in Pregnancy

12:07 - 12:15

O.C-7 Nursing Care for Lassa Fever Patients: the Use of National Early Warning Score 2 (news2) as a Prognostic Instrument

12:15 - 12:20

Question and Answer (Q&A)

12:20 - 12:28

O.C-8 Lassa Fever Disease Severity on Presentation at Kenema

FCT Hall John Schieffelin

FCT Hall

Tolulope Jegede

FCT Hall

Qasim Salau

FCT Hall

Government Hospital, Sierra Leone 12:28- 12:36

O.C-9 Neurological Presentations of Lassa Fever Mimicking Meningitis and Space-occupying Lesions: Report of Two Cases

12:36 - 12:44

O.C-10 Neonatal Presentation of Lassa Fever: Report of Three Cases

12.44 - 12.52

O.C-11 Retinal Heamorrhage as a Diagnostic and Prognostic Tool in Wilson Ovienria

FCT Hall

the Management of Lassa Fever Patients 12.52 - 13.00

O.C-12 Excretion of Lassa Fever Virus in Breast Milk and the Management of the Breastfeeding Infants: Case Series

13:00 - 13:08

O.C-13 Clinical and Virologic Response to Lassa Fever Treatment with Ribavirin at Irrua Specialist Teaching Hospital, Nigeria.

13:08 - 13:13

Question and Answer (Q&A)

13:13 - 13:15

Recap of Session

26

Chukwuyem

FCT Hall

Abejegah Ephraim Ogbaini-

FCT Hall

Emovon FCT Hall Chairs

FCT Hall

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Parallel 1 Day One: Wednesday, 16th January, 2019 Track

Laboratory Surveillance and Diagnostics

Chairs

Adebayo Adedeji, Director Laboratory Services, NCDC

Time

Title

11:15 - 11:30

O.L-1 Reliable Detection of Lassa Virus using a Combination of Two Lead presenter: Real-time Rt-pcr Assays Targeting S and L Segments Lisa Oestereich

Kano Hall

11:30 - 11:38

O.L-2 Variation in Lineage 2 Strain of Lassa Fever Virus in NigeWria

Uche Unigwe

Kano Hall

11:38 - 11:46

O.L-3 Genetic Characterization of Lassa Virus Strains Isolated from 2012 to 2016 in Southeastern Nigeria.

Olamide Oloniniyi Kano Hall

11:46 - 11:54

O.L-4 Real-time Tracking of Lassa Virus Genome Evolution in Nigeria using Nextstrain

Paul Oluniyi

Kano Hall

11:54 - 12:02

O.L-5 Metagenomic Analysis of Blood Samples Obtained from Patients Infected with Lassa Virus in Nigeria

Judith Oguzie

Kano Hall

12:02 - 12:10

O.L-6 Metagenomic Sequencing At the Epicenter of the Nigeria 2018 Lassa Fever Outbreak, Irrua, Edo State

Sophie Duraffour

Kano Hall

12:10 - 12:18

Question and Answer (Q&A)

12:18 - 12:26

O.L-7 Modeling the Triage of Suspected Lassa Fever Cases using Relasv⎠Antigen Rapid Test During January - March 2018 Lassa Fever Surge At Irrua Specialist Teaching Hospital, Edo State, Nigeria

Matthew Boisen

Kano Hall

12:26 - 12:34

O.L-8 Characterization of Virus Specific Memory T Cell Responses from Nigerian and Sierra Leonean Lassa Fever Survivors

Brian Sullivan

Kano Hall

12:34 - 12:42

O.L-9 A Systems Biology Approach to Determine Correlates of Lassa Fever Survival - the Center for Viral Systems Biology (CVISB)

Matthias Pauthner Kano Hall

12:42 - 12:50

O.L-10 How Lassa Virus Gp is Targeted by Protective Antibodies

Robert Garry

Dhamari Naidoo, Laboratory Technical Officer, WHO

AUTHOR

Room

Kano Hall

Kano Hall 27

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Parallel 1 Day One: Wednesday, 16th January, 2019 Time

Title

AUTHOR

Room

12.50 - 12:58

O.L-11 The Role of the Mobile Laboratory in the Containment of the 2013-2016 Ebola Virus Disease Outbreak in West Africa: Experience of the Nigerian-European Consortium.

Donatus Adomeh

Kano Hall

12.58 - 13.06

O.L-12 Performance Evaluation of Pan-lassa Fever Virus Rapid Diagnostic Test (RelavtmRTD) Kit in Irrua Specialist Teaching Hospital.

Ikponmwosa Odia Kano Hall

13:06- 13:13

Question and Answer (Q&A)

13:13 - 13:15

Recap of Session

Track

Vaccines and Innovations

Chairs

Melanie Saville, Head of Vaccine Development, CEPI

Kano Hall Chairs

Kano Hall

Clement Peter, WHO Country Office, Nigeria Time

Title

AUTHOR

Room

11:15 - 11:30

O.V-1 CEPI Supported Vaccine Development on Lassa Fever

Lead presenter:

Congress Hall

using Inovio’s Enhanced DNA Platform Technology 11:30 - 11:38

O.V-2 T-705-modified SSRNA in Complex with Lassa Virus

Kate Broderick Olaposi Omotuyi

Congress Hall

Olaposi Omotuyi

Congress Hall

O.V-4 A Multivalent Hemorrhagic Vaccine for Lassa, Ebola and Jonathan Heeney

Congress Hall

Nucleoprotein Exhibits Nucleotide Splaying and Increased Water Influx Into the RNA-binding Pocket 11:38 - 11:46

O.V-3 Lassa-glycoprotein Processing Enzyme (site-1 Protease) in Pf429242 Bound State: Computational Kinetics and Dynamics of Reversible Binding

11:46 - 11:54

Marburg Viruses Protects against Lethal Challenge 28

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Parallel 1 Day One: Wednesday, 16th January, 2019 Time

Title

AUTHOR

ROOM

11:54 - 12:02

O.V-5 Development of Safe and Effective Single Dose Vaccines for Hemorrhagic Fever Viruses; Preclinical Efficacy Data for Lassa Fever and Ebola as Examples

Farshad Guirakhoo

Congress Hall

12:02 - 12:10

O.V-6 A Chimpanzee Adenovirus-vectored Vaccine Confers Protection against Lethal Lassa Fever

Sarah Gilbert

Congress Hall

12:10 - 12:18

Question and Answer (Q&A)

12:18 - 12:26

O.V-7 Post-exposure Protection against Contemporary Nigerian Isolates of Lassa Fever Virus in Cynomologous Macaques with Human Monoclonal Antibodies

Robert Cross

Congress Hall

12:26 - 12:34

O.V-8 Advancement of a Lassa Fever Vaccine Clinical Trial Candidate Based on the Live Vesicular Stomatitis Virus Chimera Platform

Swati Gupta

Congress Hall

12:34 - 12:42

O.V-9 Quadrivalent Filovirus/Lassa Vaccine Demonstrates Protection against Challenge in Nonhuman Primates

Rong Xu

Congress Hall

12:42 - 12:50

O.V-10 A Broadly-protective Lassa Fever Vaccine as an Effective Tool for Fighting Lassa Fever Epidemics and Endemicity

Abdusalami Nasidi

Congress Hall

12.50 - 12:58

O.V-11 Development of Safe and Effective Vaccine against Lassa Fever in Africa

Simon Agwale

Congress Hall

12.58 - 13.06

O.V-12 Molecular Docking Studies of Compounds from Medicinal Plants on Lassa Fever Virus

Amaka Ubani

Congress Hall

13:06- 13:13

Question and Answer (Q&A)

13:13 - 13:15

Recap of Session

15:00 - 17:30

Opening Ceremony

Congress Hall

17:00 - 18:30

Reception and Welcome Night

Congress Hall

Congress Hall

Congress Hall Chairs

Congress Hall

29

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Plenary 2 Chairs

Day TWO: THURSday, 17th January, 2019 Adebola Olayinka, National Lassa Fever Research Coordinator (WHO/NCDC) Ephraim Ogbaini, Director Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital Edo

Time

Keynote Presentations

Speaker

Room

9:00 - 9:20

Lassa fever: a historical perspective and contemporary

Daniel Bausch

Congress Hall

9:20 - 9:40

New approaches in shaping the global response to VHFs

Pierre Formenty

Congress Hall

9:40 - 10:00

What do we really know about the Mastomys as host?

William Ampofo

Congress Hall

10:00 - 10:20

Using Genomic to fight Lassa Fever in Africa

Christian Happi

Congress Hall

10:20 - 10:45

Question and Answer (Q&A)

All Plenary 2

Congress Hall

development in Sierra Leone (Therapeutics and Vaccines)

Speakers

Parallel 2 Day TWO: THURSday, 17th January, 2019 Track

Epidemiology and Surveillance

Chairs

George Akpede, Consultant Peadiatrician, Irrua Specialist Teaching Hospital

Time

Title

AUTHOR

Room

14:00 - 14:15

O.E-1 Contact Tracing and Profile of Lassa Fever Contacts in Edo State: Implications for the Control of Lassa Fever Outbreaks

Lead presenter:

Congress Hall

14:15 - 14:23

O.E-2 Lassa Fever Outbreak in Enugu State, Nigeria, August 2018: the Role of Contact Tracing

Christian Akpa

Congress Hall

14:23 - 14:31

O.E-3 Burden and Trend of Lassa Fever in Nigeria: a Secondary Data Analysis 2012-2017

Onyebuchi Okoro

Congress Hall

30

Patrick Nguku, Regional Technical Advisor, African Field Epidemiology Network

Faith Ireye

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Parallel 2 Day TWO: THURSday, 17th January, 2019 Time

Title

AUTHOR

Room

14:31 - 14:39

O.E-4 Lassa Fever Sentinel Surveillance System Evaluation - Kenema District, Sierra Leone, October 2016 September, 2017

Amara Alhaji Sheriff

Congress Hall

14:39 - 14:47

Question and Answer (Q&A)

14:47 - 14:55

O.E-5 Detection of Chikungunya Virus Among Febrile Patients in Lagos, Nigeria

Sylvester Ibemgbo

Congress Hall

14:55 - 15:03

O.E-6 Epidemiology of Lassa Fever in Sierra Leone

John Schieffelin

Congress Hall

15:03 - 15:11

O.E-7 Lassa Fever Surveillance Data Analysis, Liberia, 20162017

Oscar Gbearr

15:11 - 15:19

O.E-8 The Role of Bio-surveilllance in Rumour Capture and Validation of Lassa Fever Cases Between Jan-Oct 2018 in Nigeria

Adachioma Ihueze

15:19 - 15:27

Question and Answer (Q&A)

15:27 - 15:30

Recap of Session

Track

Infection Prevention and Control

Chairs

Olufemi Ayodeji, Team Lead, Infection Control Centre, Federal Medical Centre (FMC) Owo

Time

Title

AUTHOR

14:00 - 14:15

O.I-1 Infection prevention and control in a treatment centre during a Lassa fever outbreak in southeastern Nigeria January, 2018

Lead presenter: Kano Hall Odekunle Odegbemi

14:15 - 14:23

O.I-2 Occupational Acquisition of Lassa Fever: an Intervention Study in Nigeria

Stephen Abah

Congress Hall

Congress Hall

Congress Hall Chairs

Congress Hall

Tochi Okwor, Consultant on IPC, Nigeria Centre for Disease Control

Room

Kano Hall

31

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Parallel 2 Day TWO: THURSday, 17th January, 2019 Time

Title

AUTHOR

Room

14:23 - 14:31

O.I-3 Containment of Lassa Fever Outbreak in a Southeastern Nigerian Burn Centre without Healthcare Worker Infection: the Role of Institutionalized Infection Prevention and Control Practices

Ifeanyichukwu Onah

Kano Hall

14:31 - 14:39

O.I-4 Knowledge and Compliance with Infection Prevention and Control Among Health Workers in Primary Health Care Facilities in a Lassa Fever Endemic LGA of Edo State, Nigeria

Martha Okonofua

Kano Hall

14:39 - 14:47

Question and Answer (Q&A)

Kano Hall

14:47 - 14:55

O.I-5 Management of Confirmed Lassa Fever Case in a Make-shift Tope Ojo Isolation Facility: Implications for Establishment of Lassa Fever Endemic Situation in an Area that is Lassa Fever Free

Kano Hall

14:55 - 15:03

O.I-6 Knowledge of Lassa Fever and Infection Prevention and Control Among Proprietary and Patent Medicine Vendors in Endemic Local Government Areas in Edo State: Implications for Lassa Fever Control

Ekaete Tobin

Kano Hall

15:03 - 15:11

O.I-7 Assessment of Knowledge, Attitude and Practice of Health Professionals on Safe Disposal of Corpses of Lassa Fever Cases in Southwest, Nigeria

Bamidele Oni

Kano Hall

15:11 - 15:19

O.I-8 Knowledge, Attitude and Practice of Post Exposure Francis Erah Prophylaxis of Lassa Fever Among Health Care Workers in a Tertiary Health Institution in South-South Nigeria

Kano Hall

15:19 - 15:27

Question and Answer (Q&A)

Kano Hall

15:27 - 15:30

Recap of Session

32

Chairs

Kano Hall

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Parallel 2 Day TWO: THURSday, 17th January, 2019 Track

Policy and Coordination Response

Chairs

Dan Duvall, Program Director, Global Health Protection, U.S. CDC Nigeria

Time

Title

AUTHOR

Room

14:00 - 14:15

O.P-1 Imported Lassa Fever: A Review Of The Literature And Implications For International Collaboration.

Lead presenter: Colin Brown

Edo Hall

14:15 - 14:23

O.P-2 Preparedness Of Hospitals To Handle Emerging And Reemerging Infectious Diseases In Ekiti State.

Olagoke Okimi

Edo Hall

14:23 - 14:31

O.P-3 An Assessment of States' Preparedness to Respond to Lassa Fever Outbreaks in Nigeria, 2016

Abiodun Egwuenu Edo Hall

14:31 - 14:39

O.P-4 2018 Nigeria Lassa Fever After Action Review: Lessons Learnt Malgwi Arhyel And Way Forward

Edo Hall

14:39 - 14:47

Question and Answer (Q&A)

Edo Hall

14:47 - 14:55

O.P-5 An Innovative One Health Model For Mitigating Perennial Outbreaks Of Lassa Fever At The Human-animal-ecosystem Interface In Nigeria

Daniel Oluwayelu

Edo Hall

14:55 - 15:03

O.P-6 Catastrophic Direct Medical Cost Of Lassa Fever Care By Patients Managed In Irrua Specialist Teaching Hospital, Irrua Edo State.

Emmanuel Osagiede

Edo Hall

15:03 - 15:11

O.P-7 The Role Of Incident Management System In The Containment Of The Large 2018 Lassa Fever Outbreak In Nigeria

Chioma DanNwafor

Edo Hall

15:11 - 15:19

O.P-8 Towards a forecasting system for Lassa fever in Nigeria

Gibb Rory

Edo Hall

15:19 - 15:27

Question and Answer (Q&A)

15:27 - 15:30

Recap of Session

John Oladejo, Director Health Emergency Preparedness and Response, NCDC

Edo Hall Chairs

Edo Hall

33

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE Parallel 2 Day TWO: THURSday, 17th January, 2019 Track

Risk Communication and Community Engagement

Chairs

Olufemi Ayoola, Deputy Director Risk Communications, NCDC Anisur Rahman Sidddique , Chief of C4D, UNICEF - Nigeria

Time

Title

AUTHOR

Room

14:00 - 14:15

O.R-1 The Role Of A Connect Center In Public Engagement During The 2018 Lassa Fever Outbreak In Nigeria

Lead presenter: Favour Makava

FCT Hall

14:15 - 14:23

O.R-2 Adequate Knowledge Of Lassa Fever: A Missing Link In The Control And Prevention Of The Viral Hemorrhagic Disease In Nigeria

Oloche Owoicho

FCT Hall

14:23 - 14:31

O.R-3 Stigma Associated With Lassa-fever Among Healthcare Wokers In Ondo State Nigeria

Ifeoma Idigbe

FCT Hall

14:31 - 14:39

O.R-4 Healthcare Seeking Behaviour In Lassa Fever Endemic Communities In Edo State

Alphonsus Aigbiremolen

FCT Hall

14:39 - 14:47

Question and Answer (Q&A)

14:47 - 14:55

O.R-5 Knowledge, Attitudes And Practice Towards Lassa Fever Among Health Care Workers In Faranah Health Facilities In Guinea

Mory Cherif Haidara

FCT Hall

14:55 - 15:03

O.R-6 Community Engagement For Lassa Fever Epidemiological Studies – field Experience In Edo State

Danny Asogun

FCT Hall

15:03 - 15:11

O.R-7 Community Engagement For Lassa And Other Viral Haemorrhagic Fevers: Lessons From The Ebola Response.

Akintoye Akinrinade

FCT Hall

15:11 - 15:19

O.R-8 Community Burial Practices In Nigeria And Lassa Fever Control

Anastacia Ojimba

FCT Hall

15:19 - 15:27

Question and Answer (Q&A)

15:27 - 15:30

Recap of Session

34

FCT Hall

FCT Hall Chairs

FCT Hall

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE POSTER Day TWO: THURSday, 17th January, 2019 11:15 - 13:00 - Congress Hall Mezzanine

Title

AUTHOR

P.A-01 Spatial Patterns and Abundance of Rodents in Lassa Fever Endemic Rural Villages in Guinea

Joachim Marien

P.A-02 Population Diversity of Pathogenic Mosquito-borne Arboviruses in Ilorin, Nigeria

Olatunji Kolawole

P.A-03 Seroprevalence of Rift Valley Fever Virus in One- Humped Camels (Camelus dromedarius) in Nigeria

Andrew Adamu

P.A-04 Predictors of Natal Multimammate Mouse (Mastomys natalensis) Infestation in Lassa Fever-endemic Villages of Eastern Sierra Leone

James Falasca

P.A-05 Isolation of Suspected Heamorrhagic Fever Virus and Other Arboviruses from Ticks Sampled from Livestock Hosts in Maiduguri, Nigeria

Bamidele Oderinde

P.A-06 Exploring Human-rodent Interactions in the Context of Lassa Fever, Sierra Leone

Jesse Bonwitt

P.A-07 Changes in the Seasonality of Lassa Fever in Nigeria from 2012 to 2018

Rimamdeyati Usman Yashe

P.E-8 Pathophysiology of Lassa Fever in Nigeria, Clinical Study of Acute Patients, 2011 – 2017

Lisa Oestereich

P.E-9 Incidence of Lassa Fever in Bauchi State 2012 to 2017

Adamu Garba Yusuf

P.E-10 Descriptive Analysis of Lassa Fever in Taraba State, November 2015

Adamu Ali Bukar

P.E-11 Lassa Fever Case Investigation, Bo District, Sierra Leone, February 2018

Gbessay Saffa

P.E-12 Epidemiological Review of Confirmed Lassa Fever Cases in Plateau 2016 -2018, North Central Nigeria

Simji Gomerep

P.E-13 Seroprevalence of Lassa Fever in Endemic Communities in a State in South South Nigeria

Nosa Akpede

P.E-14 Pattern of Presentation of Lassa Fever Patients at the Emergency Room in Abakaliki, Nigeria

Collins Ugwu

P.E-15 Human to Human Transmission of Lassa Fever: "Findings from Contact Follow Up During the 2018 Outbreak in Nigeria"

Adejoke Akano

35

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE POSTER Day TWO: THURSday, 17th January, 2019 11:15 - 13:00 - COngress hall Mezzanine

Title

AUTHOR

P.E-16 Introducing Electronic Data Management System During an Active Outbreak Lessons from the 2018 Lassa Fever Outbreak in Nigeria

Chukwuemeka Uzoho

P.E-17 Event based surveillance on Lassa fever outbreak response in Nigeria 2017 – 2018

Chika Ukenedo

P.C-18 Clinical Profile of Lassa Fever Patients in Abakaliki, Southeastern Nigeria, January March 2018

Joseph Agboeze

P.C-19 Prevalence of Lassa Virus Disease (LVD) in Nigerian Children

Ayodeji Andrew

P.C-20 Psychological Effects of Lassa Fever among Confirmed Cases in Irrua Specialist Teaching Hospital, 2018

Emmanuel Omomoh

P.C-21 A Review of the Use of Supportive Therapy among Lassa Fever Patients Admitted in Irrua Specialist Teaching Hospital, Edo State, Nigeria

Cyril Erameh

P.C-22 Spectrum and Pattern of Medicine Use in the Treatment of Lassa Fever in a Dedicated Treatment Centre

Sampson Owhin

P.C-23 Descriptive Epidemiology of Lassa Fever and Factors Associated with Mortality: a Three-year Review of Reported Cases in Bauchi State- Nigeria 2015 to 2017

Mohammed Abdulkarim

P.C-24 Descriptive Characterization of Lassa Fever Outbreak at Irrua Specialist Teaching Hospital from January - May, 2018

Charles Ibeneme

P.C-25 Case Series of Recrudescence in Lassa Fever- the Federal Teaching Hospital, Abakaliki (FETHA) Experience

Uche Unigwe

P.C-26 The Neglected Case of Hearing Loss Secondary to the Hemorrhagic Fevers; Ebola and Lassa

John Schieffelin

P.C-27 Impact of a Facility-based Quasi-EOC in Lassa Fever Case Management in Nigeria

Bio Belu Abaye

P.I-28 Knowledge And Practice Of Standard Precautions In Lassa Fever Control Among Healthcare Workers In 2 Local Government Areas Of Ondo State

Adeola Aderinwale

P.I-29 Multi-patient Isolation Ward to Single Isolation Unit Facility Design: Towards Better Lassa Fever Management in a Tertiary Health Centre, North Central Nigeria

Nathan Shehu

36

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE POSTER Day TWO: THURSday, 17th January, 2019 11:15 - 13:00 - COngress hall Mezzanine

Title

AUTHOR

P.I-30 Impact of Food Packaging and Storage on the Prevention and Spread of Lassa Fever in Owo, Ondo State, Nigeria

Adeoluwa Lebimoyo

P.I-31 Preparedness for Infection Prevention and Control During a Lassa Fever Outbreak in Ogun State - Nigeria, 2017

Oluwadamilola AbiodunAdewusi

P.I-32 Infection Prevention and Control Practices in the Primary Health Care Centers Following a Nosocomial Outbreak of Lassa Fever in Lagos State, Nigeria - August 2017

Oluwatosin Onasanya

P.I-33 Risk Factors for Nosocomial Infection of Lassa Fever among Health Care Workers in Nigeria

Francis Ola

P.I-34 Deployment of a Mobile Laboratory for Viral Hemorrhagic Fever Outbreak Response: Sharing the Experience of the Nigerian Mobile Molecular Laboratory in Sierra Leone

Ekaete Tobin

P.I-35 Practice of Injection Safety and Post Exposure Prophylaxis in Primary Health Care Facilities in Lassa Fever Endemic Local Government Areas, Edo State

Ekaete Tobin

P.I-36 Facility Assessment for Infection Prevention and Control Implementation in Lassa Fever Endemic Local Government Areas, Edo State

Martha Okonofua

P.I-37 Lassa Fever Infection and Prevention Control Availability and Use at Healthcare Facilities in Western Nigeria

Opeyemi Usman

P.I-38 Healthcare Waste Management: a Component of Infection Prevention and Control in a Dedicated Lassa Fever Treatment Facility in South-eastern Nigeria, 2018

Azuka Adeke

P.I-39 Safety and Cost Effectiveness of Locally Produced Re-usable Personal Protective Equipment for Lassa Fever Management in Irrua, Nigeria

Lugard Osawaru

P.R-40 Lassa Fever Control in Nigeria: Knowledge and Perception among Foodstuff Traders in Ebonyi State, Nigeria, 2017

Azuka Adeke

P.R-41 Education, Marriage Status and Gender Differences in Lassa Fever Risk Behaviour among Households Heads in Ondo State

Femi Tinuola 37

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE POSTER Day TWO: THURSday, 17th January, 2019 11:15 - 13:00 - COngress hall Mezzanine

Title

AUTHOR

P.R-42 How Prepared Are Lagos Residents to Lassa Fever Epidemic? An Urban Attitude Survey

Shola Gbadamosi

P.R-43 Knowledge, practice of standard precautions and risk perception of Lassa fever among health care workers, Federal Capital Territory Nigeria, 2018

Ramatu Abdu-aguye

P.R-44 Awareness of Lassa Fever in Bauchi State, Northeastern Nigeria

Bawa Rayyan

P.R-45 Assessment of Lassa Fever Knowledge and Preventive Practices among Rural Community Dwellers in Edo State

Danny Asogun

P.R-46 Knowledge, Attitude and Practices Regarding Lassa Fever among Adults in Endemic and Non-endemic Areas of Liberia, 2018

Ophelia Woods

P.R-47 Awareness of Lassa Fever in Rural Community in South West Nigeria

Blessing Okuonghae

P.R-48 Evaluation of Pharmacists Knowledge on Etiology, Transmission Risk and Therapeutic Management of Lassa Fever in Nigeria

Imoiboho Williams

P.R-49 Knowledge, Attitudes and Practices Pertaining to Lassa Fever Amongst Women in Igbo-Ora Community

Chidimma Ezeilo

P.P-50 One-health Approach to Lassa Fever Management in Nigeria; the Need for Policybased Intervention and Research Coordination

Otuto Amarauche Chukwu

P.P-51 Facilitating Real-time Health Information Dissemination: Outcome of a National Risk Communication Hackathon

Nestor Inimgba

P.P-52 Where Now? Contemporary Policy Directions for Lassa Fever in Sierra Leone

Rashid Ansumana

P.P-53 A Literature Review to Elucidate the Factors Advancing Lassa Fever Epidemic using a Systems Approach

Urudinachi Agbo

P.P-54 Institutional Learning for Health System Strengthening from Management of Lassa Fever: the Bingham University Teaching Hospital Experience

Christian Akude

P.P-55 Observational cohort study of Lassa fever clinical course and prognostic factors in an epidemic context in Nigeria: the LASCOPE project (2018 - Ongoing)

Alexandre Duvignaud

38

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE POSTER Day TWO: THURSday, 17th January, 2019 11:15 - 13:00 - COngress hall Mezzanine

Title

AUTHOR

P.P-56 Implementation of Policy and Co-ordination Response to Lassa Fever in Federal

Anastacia Ojimba

Medical Centre, Asaba Delta State, Nigeria P.L-57 Evaluation of the Sherlock CRISPR Technique for Diagnosis of Lassa Virus in Body

Jesssica Uwanibe

Fluids P.L-58 Retrospective Review of Turnaround Time for Lassa Fever Diagnosis in the 2018:

Kingsley Dike

P.L-59 Enhanced Lassa Virus Genomes Assembly using Shiver

Paul Oluniyi

P.L-60 Genomic Analysis of Lassa Virus During an Increase in Cases in Nigeria 2018

Philomena Eromon

P.L-61 Role of a National Public Health Laboratory in Containing the 2018 Lassa Fever

George Odigie

P.L-62 Supporting Lassa Fever Response in Nigeria through Diagnostic Development and

Devy M. Emperador

P.L-63 Molecular Characterization of Lassa Virus in Selected Endemic Areas in Nigeria

Donatus Adomeh

P.L-64 Screening of Lassa - Negative Blood Samples for Uncommon Pathogens of Acute

Muoebonam Ekene Benard

P.L-65 Molecular Characterisation of Lassa Fever Viruses from Suspected Lassa Cases in

Solomon Chollom

P.V-66 The Potential for Lassa Fever Vaccine Clinical Trials in Endemic Countries: a

Kolawole Salami

P.V-67 Molecular Analysis of a Vaccine Induced Immune Response Provides a More

Jean Boyer

P.V-68 A Measles Vector-based Vaccine to Prevent Lassa Fever

Katrin Ramsauer

P.V-69 A MVA Vaccine Candidate for Lassa Fever

Roger Hewson

Outbreak Lessons for Future Response

Outbreak in Nigeria

Lab Capacity Strengthening

Febrile Illness- Preliminary Report Jos, Plateau State, Nigeria Feasibility Study

Comprehensive Assessment of Vaccines

39

LASSA FEVER INTERNATIONAL CONFERENCE

PRESENTATION SCHEDULE POSTER Day TWO: THURSday, 17th January, 2019 11:15 - 13:00 - COngress hall Mezzanine

Title

AUTHOR

P.C-70 Assessment of Lassa Fever Sample and Case Management Preparedness in 36 States

Fatima Saleh

and Federal Capital Territory (FCT), Nigeria 2017: Challenges and Way Forward P.C-71 Factors Associated with Mortality Among PCR-confirmed Lassa Patients in Ebonyi

Chiedozie Ojide

State P.E-72 A Review of Lassa Fever Outbreaks in Nigeria 1969 - 2017: Epidemiologic Profile,

Tochi Okwor

Determinants and Public Health Response P.E-73 Lassa Fever Outbreak and Contact Tracing in Lagos State, Nigeria, January 2016

Oyeladun Okunromade

P.E-74 Outbreak of Lassa Fever in Kenema District, Sierra Leone, October 2018

Lansanna Kanneh

P.I-75 A Cluster of Nosocomial Lassa Fever Cases in Tertiary Health Facility in Nigeria:

Chioma Dan-Nwafor

Description and Lessons Learned P.L-76 Dissecting the Immune Correlates of Protection in Lassa Fever Infection

Alphonsus Ugwu

P.L-77 Exploring Viral and Social Factors Underlying High Incidence of Negative Tests in the

Katherine Siddle

Nigerian 2018 Lassa Fever Outbreak P.R-78 Risk Communication for Lassa Fever and Other Viral Haemorrhagic Fevers: a Survey

Esther Uweh

of Health Professionals in Calabar, Cross River State - October 2018 P.V-79 Development of Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-

Yohei Kurosaki

LAMP) Assay for the Detection of Lassa Virus in Nigeria P.V-80 Knowledge and Willingness of Young Adult to Participate in an Ebola Vaccine

Olubunmi Olayemi Alaka

Program in Nigeria 16:30 - 17:30

Closing Ceremony and Awards

Congress Hall

17:30 - 18:30

Cocktail and Networking

Congress Hall

40

LASSA FEVER INTERNATIONAL CONFERENCE

TRAVEL GRANT AWARDEES DIRECTORY S/NO

NAME

ORGANISATION

1

Anthony Iwuafor

UNICAL/ Consultant Microbio

2

Ifeoma Idigbe

Nigerian Institute of Medical Research

3

Nnenna Nwachukwu

Ebonyi state Ministry of Health

4

Oladipupo Ilesanmi

Hospitals’ Management Board, Ekiti State Ministry of Health

5

Ben-Chioma Adline

Rivers State University, Port Harcourt

6

Joseph Okoeguale

Irrua Specialist Teaching Hospital, Irrua, Edo State

7

Sampson Emeka

Ebonyi State Epidemiologist

8

Ifeanyichukwu Onah

National Orthopaedic Hospital Enugu, Enugu State Nigeria

9

Collins Ugwu

Federal Teaching Hospital Abakaliki, Ebonyi State

10

Olayide Olabumuyi

Community Medicine, University College Hospital

11

Adewale Adetunji

Irrua Specialist Teaching Hospital, Paediatrics, Irrua, Edo State

12

Uzoma Okebugwu

Abia State Epidemiologist

13

Uchechukwu Unigwe

Federal Teaching Hospital Abakaliki, Ebonyi State

14

Adamu Garba Yusuf

Abubakar Tafawa Balewa University Teaching Hospital (ATBUTH) Bauchi

15

Femi Tinuola

Federal University, Zamfara

16

Evbaruese Iredia

Babcock University

17

Olubunmi Alaka

Wesley Guild Hospital Unit, Ilesa, Nigeria

18

Olaitan Balogun

Ph.D Student University of Ibadan

19

Felicia Osilaechuu

20

Mukadas Hamzat

Human Kinetics and Health Education, University of Ibadan

21

Rayyan Muhammad Bawa

Specialist Hospital Bauchi, Ministry of Health, Bauchi State.

22

Andrew Adamu

University of Abuja

23

Damilola Oyedokun

University of Ibadan 41

LASSA FEVER INTERNATIONAL CONFERENCE

TRAVEL GRANT AWARDEES DIRECTORY S/NO

42

NAME

ORGANISATION

24

Simji Gomerep

University of Jos Teaching Hospital

25

Marvin Idoko

26

Jamilu Lawan

Islamic Foundation of Nigeria, Kano

27

Oguh Agada

Zonal Hospital Ankpa Kano

28

Martha Okonofua

Irrua Specialist Teaching Hospital, Irrua, Edo State

29

Yusuff Adebisi

Global Health Focus Africa

30

Kelly Iraoyah

Irrua Specialist Teaching Hospital, Irrua, Edo State

31

Ifeoma Nwadiuto

Rivers State Epidemiologist

32

Muhammad Bashar Jibril

Department of Community Medicine, Ahmadu Bello University, Zaria

33

Tolulope Jegede

Federal Medical Centre (FMC) Owo

34

Qasim Salau

Federal Medical Centre (FMC) Owo

35

Saheed Usman

Nnamdi Azikiwe University Nnewi Nigeria

36

Charles Elikwu

Babcock University Teaching Hospital

37

Ayanfe Omololu

Jos University Teaching Hospital

38

Nneka Chika-Igwenyi

Federal Teaching Hospital Abakaliki, Ebonyi State

39

Sylvester Ibemgbo

University of Lagos

40

Bamidele Oderinde

University of Maiduguri, Nigeria / WHO National Polio/ITD Lab, UMTH,

41

Josephine Isiorho

Delta Ministry of Health

42

Sampson Owhin

Irrua Specialist Teaching Hospital, Irrua, Edo State

43

Aliyu Ado Sani

Kano University of Science and Technology

44

Ifeyinwa Okafor

Federal Teaching Hospital Abakaliki, Ebonyi State

45

Chinwe Eze

Federal University of Technology (FUTO)

Maiduguri

LASSA FEVER INTERNATIONAL CONFERENCE

TRAVEL GRANT AWARDEES DIRECTORY S/NO

NAME

ORGANISATION

46

Itohan Alili

Irrua Specialist Teaching Hospital Irrua, Edo State

47

Peter Akhideno

Irrua Specialist Teaching Hospital Irrua, Edo State

48

Nathan Shehu

Jos University Teaching Hospital

49

Ifeanyi Onah

University of Nigeria, Nsukka

50

Blessing Okuonghae

Federal University of Agriculture, Abeokuta.

51

Michael Benjamin

Young Professional for Agricultural Development

52

Daniel Oluwayelu

University of Ibadan

53

Chidinma Ezeilo

54

Temitope Ojo

Babcock University Teaching Hospital

55

Danny Asogun

Irrua Specialist Teaching Hospital Irrua

56

Adeoluwa Lebimoyo

FEGG FARMS

57

Otuto Amarauche

University of Nigeria, Nsukka

58

Amaka Ubani

Jos University Teaching Hospital

59

Simeon Okafor

University of Nigeria, Nsukka

60

Josephine Alabi

Federal Medical Centre (FMC) Owo

61

Nnennaya Anthony Ajayi

Federal Teaching Hospital Abakaliki, Ebonyi State

62

Sylvester Adeyemi

Healthway Pharmacy Oron, Akwa ibom state

63

Chukwuyem Abejegah

Federal Medical Centre (FMC), Owo

64

Esther Uweh

University of Uyo, Akwa Ibom

65

Nsidibe Ekpeyong

66

Iheanyi Nwankwo

67

Mojeed Rafiu

Irrua Specialist Teaching Hospital, Irrua, Edo State

68

Njoku Jackson Grant

Nnamdi Azikiwe University, Nnewi 43

LASSA FEVER INTERNATIONAL CONFERENCE

TRAVEL GRANT AWARDEES DIRECTORY S/NO

44

NAME

ORGANISATION

69

Urudinachi Agbo

Federal Teaching Hospital Abakaliki, Ebonyi State

70

Aigbiremolen, Alphonsus Oriaifo

Cedar Centre for Health and Development, Ekpoma, Edo State

71

Ekaete Tobin

Irrua Specialist Teaching Hospital, Paediatrics, Irrua, Edo State

72

Odia Ikponmwosa

Irrua Specialist Teaching Hospital, Paediatrics, Irrua, Edo State

73

Adomeh Donatus

Irrua Specialist Teaching Hospital, Paediatrics, Irrua, Edo State

74

Ephraim Ogbaini

Irrua Specialist Teaching Hospital, Paediatrics, Irrua, Edo State

75

Ighodo Yemi

Irrua Specialist Teaching Hospital, Paediatrics, Irrua, Edo State

76

George Odigie

Irrua Specialist Teaching Hospital, Paediatrics, Irrua, Edo State

77

Oboh Olele Joy

Irrua Specialist Teaching Hospital, Paediatrics, Irrua, Edo State

78

Nosa Akpede

Irrua Specialist Teaching Hospital, Paediatrics, Irrua, Edo State

79

Imam Bello

State Epidemiologist

80

Stephen Fagbemi

Ondo State Epidemiologist

81

Bruce Osa

State Ministry of Health, Deputy Director Disease Control

82

Lawrence Ofori-Boadu

Noguchi Memorial Institute for Medical Research, University of Ghana, Accra

83

Richard Suu-Ire

Noguchi Memorial Institute for Medical Research, University of Ghana, Accra

84

Stella Onwah

University of Benin

85

Gloria Eifediyi

86

Demian Nwidi

Federal Teaching Hospital Abakaliki, Ebonyi State

87

Chiedozie Ojide

Federal Teaching Hospital Abakaliki, Ebonyi State

88

Yemisi Ighodalo

Irrua Specialist Teaching Hospital, Paediatrics, Irrua, Edo State

89

Robinson Onoh

90

Joseph Shaibu

Nigerian Institute of Medical Research (NIMR)

LASSA FEVER INTERNATIONAL CONFERENCE

TRAVEL GRANT AWARDEES DIRECTORY S/NO

NAME

ORGANISATION

92

Pelumi Adebiyi

University College Hospital, Ibadan

93

George Akpede

Irrua Specialist Teaching Hospital Irrua, Edo State

94

Ikoma Obunge

University of Port Harcourt Teaching Hospital

96

S. A. Omilabu

College of Medicine, University of Lagos

97

Tunde Salako

Nigerian Institute of Medical Research (NIMR)

98

Chukwuma Muanya

The Guardian Newspapers

99

Ebede Samuel Onuzulike

University of Nigeria Teaching Hospital (UNTH)

100

Ekene Muoebonam

Irrua Specialist Teaching Hospital, Irrua, Edo State

91

Bamidele Nyemike Ogunro

45

LASSA FEVER INTERNATIONAL CONFERENCE

NOTES

46

GROUND FLOOR LEVEL, TRANSCORP HILTON, ABUJA

EDO HALL FCT

CONGRESS HALL HALL

FCT HALL

CONG

RESS

ME ZZ

ANINE

MEZZANINE FLOOR LEVEL, TRANSCORP HILTON, ABUJA

KANO HALL

NIGERIA CENTRE FOR DISEASE CONTROL Plot 801, Ebitu Ukiwe Street, Jabi, Abuja, Nigeria +234-800-970000-10 http://lic.ncdc.gov.ng lfconference@ncdc.gov.ng info@ncdc.gov.ng

CONTACTS General information: Chioma Dan-Nwafor – 0803 674 3774 Visa on arrival: Tarik Mohammed – 0803 618 8228 Speakers presentations: Abiodun Egwuenu – 0803 351 6191 Hotel accommodation: Stella Inweregbu – 0706 825 6011

Security: Anwar Mohammed – 0813 383 8313 Medical: Fatima Saleh – 0803 615 0927

Programme Organisers The Lassa Fever International Conference acknowledges the invaluable contributions of the time and energy spent by staff of the Nigeria Centre for Disease Control and its partners. Their efforts are critical to the success of the conference.

DESIGN & LAYOUT: BOBOYE ONDUKU/BLO’COMMS, 2019

Airport pick up and shuttle buses: Damilola Kolade – 0701 842 0445